News

impact of biological barriers on inhaled antibodies

😊 Excited to share our latest publication in European Journal of Pharmaceutics and Biopharmaceutics on the impact of biological barriers…

😀 Great ANR-2025 results for the CEPR!! 👏 Congratulations to Christophe Paget and Nathalie Heuzé-Vourc’h for their participation in the…

A relaxation day at the CEPR !!Bowling and billiards are on the agenda for this summer event ! A wonderful…

👏 Very proud of the CEPR INSERM Lab PhD students!! Oral presentation and posters for the Centre-Val de Loire Region…

We are presenting a concise overview of the existing rationale and evidence and provide guidance for implementing inhaled antibiotics among…

The Team 3 (Virginie Hervé, Sandrine Le Guellec & Mike Pasteur) was recently on air during La Méridienne, the daily radio…

From the ocean depths to the laboratory bench, deep sea bacteria to combat respiratory diseases. Congratulations to Alexis DAVID…

The EU-funded FAIR project has reached a major milestone with the start of a Phase I clinical trial for FLAMOD,…

The PEPR 2024 project is coordinated by Mathieu Epardaud (ISP – INRAe/University of Tours) and Thomas Sécher (CEPR – Team…

End of Content.